Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
12/2005
12/01/2005US20050267106 For therapy of respiratory complaints
11/2005
11/30/2005CN1229335C Nervinolin derivatives
11/29/2005US6969715 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
11/24/2005WO2005111005A1 Novel enantiomerically pure beta-agonists, method for the production and the use thereof in the form of a drug
11/24/2005WO2005111004A1 Novel sustained-action bronchodilating agents for use in the treatment of respiratory diseases
11/24/2005WO2005111002A2 Substituted cycloalkyl derivatives for use in the treatment of respiratory diseases
11/24/2005WO2005110990A1 Hydroxy-substituted benzo-condensed heterocycles for use as beta agonists in the treatment of respiratory diseases
11/24/2005US20050261343 Anthranilamides and their use as pharmaceutical agents
11/24/2005US20050261311 Piperizinones as modulators of chemokine receptor activity
11/24/2005US20050261308 1-(2-Chloro-6-piperazin-1-yl-pyrimidin-4-ylmethyl)-3,4-dihydro-1H-quinolin-2-one; substituted benzoxazinone compounds; 5-HT6 modulators/antagonists; Parkinson's disease, Huntington's disease, manic depression, psychoses, Alzheimer's disease and memory disorders
11/24/2005US20050261291 1-Cyclopropylmethyl-4-[2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine or a salt or hydrate; exhibit excellent cell adhesion inhibitory action or cell infiltration inhibitory action; for treating inflammatory diseases and autoimmune diseases such as inflammatory bowel diseases and rheumatoid arthritis
11/24/2005US20050261290 Novel compounds of proline and morpholine derivatives
11/24/2005US20050261286 Substituted cycloalkyl derivatives, process for the manufacture thereof and use thereof as medicament
11/24/2005CA2565548A1 Substituted cycloalkyl derivatives for use in the treatment of respiratory diseases
11/24/2005CA2565243A1 Hydroxy-substituted benzo-condensed heterocycles for use as beta agonists in the treatment of respiratory diseases
11/24/2005CA2565026A1 Novel sustained-action bronchodilating agents for use in the treatment of respiratory diseases
11/23/2005EP1598344A1 Nile red light-emitting compound, method for producing nile red light-emitting compound, and light-emitting device
11/23/2005EP1597322A2 Metal complexes as light-absorbing compounds in the information layer of optical data carriers
11/23/2005EP1597244A1 Ethynyl derivatives serving as factor xa inhibitors
11/23/2005EP1373232B1 Method for producing n-substituted 2,6-dialkyl morpholines
11/23/2005CN1700922A 3, 10, and 12a substituted tetracycline compounds
11/22/2005US6967251 Reagents for labeling biomolecules having aldehyde or ketone moieties
11/22/2005US6967250 preferably in form of cassettes which enable their attachment to variety of biological materials; dyes and reagents made from them offer wide variety of fluorescent labels with large Stokes' shifts enabling their use in variety of applications
11/22/2005CA2187174C .alpha.-substituted phenylacetic acid derivative, process for producing the same, and agricultural bactericide containing the same
11/17/2005WO2005108381A1 Synthesis and uses of synephrine derivatives
11/17/2005WO2005108359A1 Novel compounds of proline and morpholine derivatives
11/17/2005WO2005016264A3 Diamine derivatives of quinone and uses thereof
11/17/2005WO2004098504A3 Antitumor 2-aminocarbonyl-1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazines and methods of treating tumors
11/17/2005US20050256114 substituted 4H-benzo[1,4]oxazin-3-one derivatives, having antagonistic activity at muscarinic receptors and agonistic activity at adrenergic receptors; chronic obstructive pulmonary disease; asthma; bronchitis; adult respiratory distress syndrome
11/17/2005CA2565843A1 Novel compounds of proline and morpholine derivatives
11/16/2005EP1595873A1 Substituted cycloalkyl derivatives for the treatment of respiratory diseases
11/16/2005EP1595872A1 Fluorescent compounds for monitoring protein-lipid binding
11/16/2005EP1594853A1 Method for the production of bicyclic aromatic amino acids and intermediate products thereof
11/15/2005US6964973 Nonsteroidal agonists and antagonists
11/10/2005WO2005105776A1 Arylsulfonyl benzodioxanes useful for modulation the 5-ht6 receptor, the 5-ht2areceptor or both
11/10/2005WO2005105764A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/10/2005WO2005105763A1 Substituted morpholine compounds for the treatment of central nervous system disorders
11/10/2005WO2005105100A1 Morpholine compounds
11/10/2005US20050250944 Synthesis and uses of synephrine derivatives
11/10/2005US20050250943 Arylsulfonyl benzodioxanes, benzoxazines and benzothiazines as 5-HT6 antagonists
11/10/2005US20050250775 Novel compounds
11/10/2005US20050250152 fluorescent derivatization reagents that label substances containing aldehydes, ketones, and similar functional groups, and their use in labeling glycoproteins and glycopeptides, nucleic acids and lipopolysaccharides, and other biomolecules
11/10/2005CA2566196A1 Arylsulfonyl benzodioxanes useful for modulating the 5-ht6 receptor, the 5-ht2a receptor or both
11/10/2005CA2565184A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/10/2005CA2564994A1 Substituted morpholine compounds for the treatment of central nervous system disorders
11/10/2005CA2563959A1 (1,10b-dihydro-2-(aminocarbonyl-phenyl)-5h-pyrazolo[1,5-c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as hiv viral replication inhibitors
11/10/2005CA2563063A1 Purification of progesterone receptor modulators
11/09/2005EP1592684A1 Malonamide derivatives as gamma-secretase inhibitors
11/09/2005EP1149066B1 Method of preparing alkylated salicylamides
11/09/2005EP1095016B1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
11/09/2005CN1694873A Vanilloid receptor ligands and their use in treatments
11/09/2005CN1226295C Preparation method of important intermediate for mosapride citrate
11/03/2005WO2005103018A1 Urea derivatives as antagonists of the vanilloid receptor (vr1)
11/03/2005WO2005044201A3 Ph sensitive prodrugs of 2,6-diisopropylphenol
11/03/2005US20050245519 Substituted morpholine compounds for the treatment of central nervous system disorders
11/03/2005US20050245512 Method and composition for rejuvinating cells, tissues organs, hair and nails
11/03/2005US20050245408 Sustained release; controlled chemical cascade; storage stability
11/03/2005CA2563494A1 Urea derivatives as antagonists of the vanilloid receptor (vr1)
11/02/2005EP1590340A1 Inhibitors of histone deacetylase
11/02/2005EP1590319A1 Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
11/01/2005US6960581 1-amino-2-hydroxy-butane or 2-hydroxy-butanamide derivatives
10/2005
10/27/2005WO2005100333A1 Methods and intermediates for the synthesis of delta-9 tetrahydrocannabinol
10/27/2005WO2005100325A1 Aryl glycinamide derivatives and their use as nk1 antagonists and serotonin reuptake inhibithors
10/27/2005WO2005099688A2 Cyclic compounds
10/27/2005WO2005061491A3 Aralkyl and aralkylidene heterocyclic lactams with affinity for 5-ht1 receptors
10/27/2005WO2005034848A3 Inhibitors of cathepsin s
10/27/2005US20050240015 Solution phase synthesis of oligonucleotides
10/27/2005US20050239860 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
10/27/2005US20050239849 Substituted phenoxyacetic acids
10/27/2005US20050239828 Spirocyclic amides as cannabinoid receptor modulators
10/27/2005US20050239802 E.g., 6-{2-[5-Chloro-2-(2,4-difluorobenzyloxy)- phenyl]cyclopent-1-enyl}-pyridine-2-carboxylic acid, used to treat prostaglandin mediated diseases that include inflammatory, neuropathic or visceral pain
10/27/2005US20050239054 Drug screening compounds having esterified phosphonate or carboxyl groups with novel enzyme GS-7340 Ester Hydrolase and identifying the compound as a suitable prodrug by the formation of a phosphonic acid or carboxylic acid; candidate compounds
10/27/2005CA2562244A1 Cyclic compounds
10/26/2005EP1289965B1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
10/26/2005CN1688527A Fused benzene derivative and use
10/26/2005CN1687039A Method for synthesizing (3s-cis)-benzoyl methyl ester-[4-(6-methyl-2, 5-diketone-3-morpholinyl)butyl]-amino formic acid
10/25/2005CA2147056C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
10/20/2005WO2005097761A1 Heterocyclic phenylaminopropanol derivatives as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (vms)
10/20/2005WO2005097744A1 1-(1h-indol-1-yl)-3-(4-methylpiperazin-1-yl)-1-phenyl propan-2-ol derivatives and related compounds as modulators of the norepinephrine (ne) and the serotonine (5-ht) activity and the monoamine reuptake for the treatment of vasomotor symptoms (vms)
10/20/2005WO2005030794B1 Hemiasterlin derivatives and uses thereof
10/20/2005US20050234058 Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use
10/20/2005US20050234050 Ph sensitive prodrugs of 2,6-diisopropylphenol
10/20/2005CA2560967A1 1-(1h-indol-1-yl)-3-(4-methylpiperazin-1-yl)-1-phenyl propan-2-ol derivatives and related compounds as modulators of the norepinephrine (ne) and the serotonine (5-ht) activity andthe monoamine reuptake for the treatment of vasomotor symptoms (vms)
10/20/2005CA2560966A1 Heterocyclic phenylaminopropanol derivatives as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (vms)
10/19/2005EP1586567A1 Compounds useful in the treatment of inflammatory diseases
10/19/2005EP1585730A1 Carboxamide derivatives and their use as factor xa inhibitors
10/19/2005EP1463714A4 Vanilloid receptor ligands and their use in treatments
10/19/2005EP1397170B1 Safety shield system for prefilled syringes
10/18/2005US6956034 Oxazin(ethyl)one compounds used as fungicides
10/18/2005US6956033 3,4-dihydroisoquinoline derivative compound and a pharmaceutical agent comprising it as active ingredient
10/18/2005CA2156288C Glycerol derivative, device and pharmaceutical composition
10/13/2005WO2005095440A1 BETA-AMINOACID-DERIVATIVES AS FACTOR Xa INHIBITORS
10/13/2005WO2005095338A1 Alkoxyphenylpropanoic acid derivatives
10/13/2005US20050227986 Vanilloid receptor ligands and their use in treatments
10/13/2005US20050227982 Antileishmanial dinitroaniline sulfanomides with activity against parasite tubulin
10/13/2005US20050227981 Aralkyl and aralkylidene heterocyclic lactam and imides
10/13/2005US20050227975 Treatment of inflammatory and obstructive respiratory complaints; 1-{3-[2-hydroxy-2-(6-hydroxy-3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-8-yl)-ethylamino]-3-methyl-butyl}-6-methoxy-4,4-dimethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one; potent, high degree of selectivity to the beta 2-adreno-receptor
10/13/2005US20050227969 A piperidin-2-one, 1,3-oxazinan-2-one, or 1,3-thiazinan-2-one compound for treatment of glaucoma, mediating the bone modeling and remodeling processes of the osteoblasts and osteoclasts; 7-{(4S)-4-[(3R)-3-hydroxy-4-phenylbutyl]-2-oxo-1,3-oxazinan-3-yl}heptanoic acid; side effect reduction
10/13/2005US20050224756 3,3,4,4-Tetrafluorocyclopentane compounds, used as components of liquid crystal media
10/13/2005CA2559948A1 Beta-aminoacid-derivatives as factor xa inhibitors
1 ... 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 ... 112